Survival analysis in both non-ICI-treated cohort and TCGA cohort revealed longer median OS in EPHAT-WT instead of EPHA7-MUT patients, indicating that EPHA7-MUT might potentially have a worse prognostic impact on cancer patients. The gene discussed is EPHA7; the disease is cancer.